Mike Thompson, MD, PhD, FASCO
@mtmdphd
Views my own. VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #CCC19 @COVID19nCCC @ASCO COI: coi.asco.org/share/RBB-TT6R…
ID: 190337035
https://www.linkedin.com/in/michaelthompsonmdphd/ 13-09-2010 18:03:36
144,144K Tweet
23,23K Followers
3,3K Following
Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma [Jan 30, 2023] Eddie Cliff et al. Journal of Clinical Oncology ascopubs.org/doi/full/10.12… #mmsm #ImmunoOnc #IDonc
![Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma [Jan 30, 2023] <a href="/Eddie_Cliff/">Eddie Cliff</a> et al. <a href="/JCO_ASCO/">Journal of Clinical Oncology</a> ascopubs.org/doi/full/10.12… #mmsm #ImmunoOnc #IDonc](https://pbs.twimg.com/media/GMgK4ynW8AAoQYO.jpg "Mike Thompson, MD, PhD, FASCO (@mtmdphd) on Twitter photo Acknowledging Infection Risk in Bispecific Antibody Trials in the Treatment of Multiple Myeloma [Jan 30, 2023] <a href=\"/Eddie_Cliff/\">Eddie Cliff</a> et al. <a href=\"/JCO_ASCO/\">Journal of Clinical Oncology</a> ascopubs.org/doi/full/10.12… #mmsm #ImmunoOnc #IDonc")